Health·2,827 stories
Tenax Therapeutics is days from a Phase 3 readout for an oral heart failure treatment tied to pulmonary hypertension — a binary event that could more than double its stock or erase it entirely.
Biotech entrepreneur Greg Verdine is enjoying a standout year, with his company Parabilis Medicines completing one of the industry's largest recent IPOs and his other venture LifeMine raising $263 mil
An opinion piece in STAT+ argues that a new Nature Medicine study's headline question — "Is AI actually improving healthcare?" — misses the point, since AI tools in medicine are not interchangeable an
An 85-million-year timeline maps human evolution from early primates through ancient hominins like Ardipithecus and Australopithecus, highlighting fossil evidence and ongoing debates over when, where,
The UK government will create nearly 200 community mental health centres and mental health A&Es across England by 2029, including 100 walk-in hubs in high street banks and libraries, backed by £343m.
A new study of over 1,000 rheumatoid arthritis patients in South Korea found that fine particulate matter (PM2.5) significantly worsens disease activity and raises the risk of painful flare-ups, espec
In a double-blind, placebo-controlled trial of more than 170 PTSD patients, the prescription THC drug Dronabinol cut nightmare severity significantly more than placebo over ten weeks, with over a thir
The FDA approved Moderna's mFlusiva, the first licensed mRNA flu vaccine, for adults 50 and older — reversing a February refusal-to-file notice from then-FDA biologics chief Vinay Prasad, who departed
Longtime ESPN college basketball announcer Dick Vitale, 87, shared encouraging blood test results on social media this week, saying his immunotherapy treatments are proving 'very effective in wiping o
UK firm Stablepharma trialled a fridge-free tetanus-diphtheria vaccine in 60 volunteers, using a trehalose-stabilized dry powder that sat at room temperature for a year, in a bid to curb the cold-chai
The FDA approved Takeda's twice-daily pill Orzeyful for narcolepsy type 1, validating an orexin receptor agonist drug class that outperformed existing stimulant and oxybate therapies in Phase 3 trials
FDA and CMS officials convened 10 AI health companies at a closed-door 'clinical AI demo day' on July 8 to see AI doctor technology firsthand as regulators shape rules for clinical AI adoption and pay
The FDA and CMS hosted a closed-door 'clinical AI demo day' on July 8 at FDA's White Oak headquarters, inviting leaders from 10 companies — including Anthropic, Microsoft AI, and Amazon One Medical —
A long-term NYU Langone study of more than 12,000 Americans found that avoiding high blood pressure, type 2 diabetes, and smoking in midlife was linked to nearly 13 additional years free of dementia c
A 26-year study of over 12,000 US adults found that avoiding smoking, diabetes, and high blood pressure in midlife adds roughly 13 dementia-free years compared to having all three risk factors.
A small clinical trial found that swallowing capsules containing healthy donor faeces helped six adults with peanut allergy tolerate more peanut four months later, advancing the case that gut microbes
Chinese gene-editing startup HuidaGene went silent for 15 months after presenting underwhelming early CRISPR trial data for Duchenne muscular dystrophy, saw its CEO and CTO depart, and only issued an
Novo Nordisk's status as Europe's most valuable company is under threat as Eli Lilly overtakes it in the lucrative GLP-1 weight-loss drug market it pioneered with Ozempic.
When serious illness hits a U.S. household, caregiving often falls to whoever is home — including, as one teenager's case shows, children handling surgical drains, medications, and medical appointment
Scientists at Kindred Companion Sciences used CRISPR to switch off the gene producing canine allergens, creating two beagles — Bailey and Alfie — born in September 2024 whose saliva and fur lack the k
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.